Double attack on tumors: freeze then irradiate shows promise in early trial
NCT ID NCT07450352
First seen Mar 04, 2026 · Last updated Jun 16, 2026 · Updated 22 times
Summary
This study tests a new approach for people with solid tumors that cannot be surgically removed. It combines two treatments: freezing the tumor (cryoablation) and placing tiny radioactive seeds inside it (iodine-125). The goal is to see if doing both steps works better than either treatment alone at controlling the tumor. About 150 adults with various cancers will take part, and the study will measure how long the tumor stays under control and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
The 960th Hospital of People's Liberation Army (PLA)
Jinan, Shandong, 250031, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.